TSX:WEED (Canopy Growth)
About WEED
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Canopy Growth (TSX: WEED) Latest News

Investing
3 Big Opportunities for MedReleaf Corp.
Investing
The Problems With Investing in Cannabis Companies
Investing
Are Canadian Marijuana Stocks Value Plays Right Now?

Investing
What Happens to Canadian Marijuana Stocks if Legalization Is Pushed to 2019?

Investing
Will 2018 Be the Year the Canadian Government Legalizes Marijuana?

Investing
Does Canopy Growth Corp. Have Long-Term Potential?
Investing
These 3 Stocks Have Doubled in the Past 12 Months

Investing
Canopy Growth Corp. Investors Learn the Hard Way That Profits Matter

Investing
These 2 Marijuana Stocks Can Spark Your Portfolio
Investing
Canopy Growth Corp.: Is This Stock Attractive at $8 Per Share

Investing
Another $6 Billion Question for Canada’s Marijuana Industry
